Cargando…

5613458 BLOOD MICROPARTICLES: A TOOL OF EVALUATING THE EFFECT OF TRANSFUSION IN SICKLE CELL DISEASE PATIENTS

Detalles Bibliográficos
Autores principales:	Khalfaoui, K., Chebbi, M., Safra, I., Barmate, M., Chaouechi, D., Benkhaled, M., Ouederni, M., Mellouli, F., Menif, S., Moumni, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	e-Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112624/ http://dx.doi.org/10.1097/01.HS9.0000928464.21929.65

Ejemplares similares

P105: BLOOD MICROVESICLES AS BIOMARKERS TO PREDICT VASO-OCCLUSIVE CRISIS IN SICKLE CELL ANEMIA
por: Chebbi, M, et al.
Publicado: (2022)

P106: EARLY PREVENTIVE DIAGNOSIS OF HEMOLYTIC ANEMIA IN SICKLE CELL PATIENTS BY DETECTING THE TRIGGERING OF ERYPTOSIS.
por: Khalfaoui, K, et al.
Publicado: (2022)

5613312 PLASMATIC MICROPARTICLES AS POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF BETA THALASSEMIA
por: Chebbi, M., et al.
Publicado: (2023)

PB2543: CIRCULATING MICROVESICLES AS POTENTIAL CELLULAR BIOMARKERS FOR THROMBOTIC RISKS IN BETA THALASSEMIA
por: Chebbi, Mariem, et al.
Publicado: (2023)

P-077: POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE
por: I., MOUMNI, et al.
Publicado: (2022)

5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA
por: Dewi, M.K.D., et al.
Publicado: (2023)

5567917 COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE
por: Sweerts, L., et al.
Publicado: (2023)

Inflammatory properties of microparticles in stored red blood cell transfusion products
por: Straat, M, et al.
Publicado: (2014)

P-102: HEALTH LITERACY LEVEL ASSOCIATED WITH THALASSEMIA AMONG TUNISIAN’S YOUTH AND PROSPECTS FOR PRIMARY PREVENTION
por: F., MAAOUI, et al.
Publicado: (2022)

Microparticles from red blood cell transfusion products induce a strong inflammatory host response
por: Straat, M, et al.
Publicado: (2015)

5596737 RETINOPATHY IN EGYPTIAN PATIENTS WITH SICKLE CELL DISEASE
por: Hassan, T.H., et al.
Publicado: (2023)

5610614 ASSESSING PHYSICAL, SOCIAL AND EMOTIONAL IMPACT OF SICKLE CELL DISEASE IN PORTUGUESE PATIENTS: AN OBSERVATIONAL, MULTICENTER STUDY (ASCEND)
por: Christopher Saunders, C.S., et al.
Publicado: (2023)

5597199 AGEING WITH SICKLE CELL ANEMIA AND HOW TO FACE IT
por: Kreka, M.K., et al.
Publicado: (2023)

5610178 SURVIVAL AND COMPLICATIONS IN PATIENTS WITH HEMOGLOBINOPATHIES: THE EXPERIENCE OF A SINGLE DEPARTMENT OF THALASSEMIA AND SICKLE DISEASE
por: Xydaki, X.A., et al.
Publicado: (2023)

5610603 CLINICAL AND GENETIC PREDICTORS OF SICKLE CELL NEPHROPATHY IN MALAWI
por: Banda, K.H.B., et al.
Publicado: (2023)

P-044: RETROSPECTIVE STUDY OF POST-TRANSFUSION ALLOIMMUNIZATION IN THE SICKLE CELL POPULATION OF THE CHR CITADELLE
por: E., SEPULCHRE, et al.
Publicado: (2022)

5607560 AN AUDIT OF COMPLIANCE WITH NEONATAL SCREENING GUIDELINES IN NEONATES DIAGNOSED WITH SICKLE CELL DISEASE IN SOUTH WALES
por: Pasha, S.R.P., et al.
Publicado: (2023)

5588571 DYSLIPIDEMIA IN TRANSFUSION-DEPENDENT-THALASSEMIA PATIENTS AND ITS CORRELATION WITH SERUM VITAMIN D LEVEL
por: El-Ghamrawy, M., et al.
Publicado: (2023)

5566409 IMPACT OF GENETIC VARIATIONS ON THROMBOTIC RISK OF SICKLE CELL DISEASE IN SAUDI PATIENTS
por: Alshabeeb, M.A., et al.
Publicado: (2023)

5589865 PRELIMINARY FINDINGS FROM THE FOLLOW-UP OF PREGNANT SICKLE CELL DISEASE PATIENTS IN LUANDA, ANGOLA.
por: Brito, M., et al.
Publicado: (2023)

5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE
por: Maran, J.E.M., et al.
Publicado: (2023)

5574716 PROBLEMS AND STRATEGIES OF BLOOD TRANSFUSION IN THALASSEMIA DURING COVID-19 PANDEMIC IN INDONESIA
por: Rahmartani, L.D.R., et al.
Publicado: (2023)

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE
por: Xydaki, A.X., et al.
Publicado: (2023)

5588995 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOLOGICAL INTERVENTIONS FOR SICKLE CELL DISEASE IN CHILDREN AND ADOLESCENTS: A NETWORK META-ANALYSIS
por: Tonin, F.S., et al.
Publicado: (2023)

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT -THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER
por: Maria Vousvouki, M.V., et al.
Publicado: (2023)

Blood transfusion during cardiac surgery: massive transfusion coagulopathy
por: Trlaja, A, et al.
Publicado: (2013)

5612560 A MONITORING AND EVALUATION FRAMEWORK AND ASSOCIATED TOOLS FOR THE SICKLEINAFRICA CONSORTIUM
por: Nembaware, V., et al.
Publicado: (2023)

5612976 FIRST ADMINISTRATION OF HYPOXIC BLOOD IN A TRANSFUSION-DEPENDENT PATIENT
por: Reikvam, H., et al.
Publicado: (2023)

5613019 THE CO-EXISTENCE OF SICKLE CELL DISEASE WITH NEUROFIBROMATOSIS: A CASE REPORT
por: Crombie, K., et al.
Publicado: (2023)

5613251 RAPIDLY PROGRESSING MOYAMOYA SYNDROME IN SICKLE CELL DISEASE -- CASE REPORT
por: Joana, J.L., et al.
Publicado: (2023)

5610131 A STANDARDISED LANGUAGE TAG PROTOCOL AND WORKFLOW FOR DEVELOPING AND MANAGING MULTILINGUAL ONTOLOGIES: SHOWCASING THE FRENCH SICKLE CELL DISEASE ONTOLOGY (SCDO)
por: Hotchkiss, J., et al.
Publicado: (2023)

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US
por: Sunil Bhandari, S.B., et al.
Publicado: (2023)

5597164 BURDEN AND RISK FACTOR TO ACUTE MYOCARDIAL ISCHAEMIA IN CHILDREN WITH SICKLE CELL ANAEMIA
por: Adeniyi, O.D., et al.
Publicado: (2023)

P-083: IMPACT OF ALPHA THALASSEMIA COEXISTENCE ON TRANSFUSION NEED AMONG PATIENTS WITH SICKLE CELL DISEASE
por: A., MADRUGA DE OLIVEIRA LAGROTTA PITTELLA, et al.
Publicado: (2022)

P-072: COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE.
por: S., AL KINDI, et al.
Publicado: (2022)

5607225 ADDITION OF THERAPEUTIC PLASMA EXCHANGE TO RED CELL EXCHANGE IMPROVES OUTCOMES OF FAT EMBOLISM SYNDROME IN SICKLE CELL DISEASE
por: Tsitsikas, D.A., et al.
Publicado: (2023)

5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

P-061: DE NOVO APPEARANCE OF VACUOLES IN TRANSFUSED RED BLOOD CELLS IN SICKLE CELL DISEASE PATIENTS WITH DEFECTIVE SPLENIC FUNCTION
por: L., DUMAS, et al.
Publicado: (2022)

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
por: POWER-HAYS, A., et al.
Publicado: (2022)

5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.
por: Manganas, K.M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p852fsukhta2ke926ka454474d